Two Sigma Investments’s Phio Pharmaceuticals PHIO Stock Holding History
Bought
Maintained
Sold
Other funds holding PHIO
Two Sigma Investments's PHIO Position: Q3 2026 in Review
Two Sigma Investments increased its Phio Pharmaceuticals (PHIO) stake by 161% in Q3 2026, buying an estimated $36.5K and bringing the position to 56,057 shares worth $57.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4744.
Two Sigma Investments first reported a position in PHIO in Q2 2021 and has held it in 10 quarters since. The position peaked at $129K in Q4 2021. 23 funds tracked by Wall St. Rank hold PHIO as of Q3 2026.
- Two Sigma Investments held 56,057 shares of Phio Pharmaceuticals worth $57.7K as of Q3 2026.
- Two Sigma Investments bought 34,556 Phio Pharmaceuticals shares in Q3 2026, an estimated $36.5K.
- Phio Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #4744 holding.
- Two Sigma Investments first reported a position in Phio Pharmaceuticals in Q2 2021 and has held it in 10 quarters since.
- Two Sigma Investments's Phio Pharmaceuticals position peaked at $129K in Q4 2021.
- 23 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.